2.74
Schlusskurs vom Vortag:
$2.74
Offen:
$2.76
24-Stunden-Volumen:
17,377
Relative Volume:
0.09
Marktkapitalisierung:
$7.42M
Einnahmen:
$202.00K
Nettoeinkommen (Verlust:
$-28.96M
KGV:
-4.5667
EPS:
-0.6
Netto-Cashflow:
$-21.85M
1W Leistung:
+3.59%
1M Leistung:
+11.84%
6M Leistung:
+2,140%
1J Leistung:
+914.81%
AIM ImmunoTech Inc Stock (AIM) Company Profile
Firmenname
AIM ImmunoTech Inc
Sektor
Branche
Telefon
352 448 7797
Adresse
2117 SW Highway 484, Ocala, FL
Vergleichen Sie AIM mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AIM
AIM ImmunoTech Inc
|
2.74 | 7.42M | 202.00K | -28.96M | -21.85M | -0.60 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
AIM ImmunoTech Inc Aktie (AIM) Neueste Nachrichten
Why AIM ImmunoTech Inc. stock remains top rated2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com
Will AIM ImmunoTech Inc. (HXB) stock benefit from Fed rate cutsJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - newser.com
Will AIM ImmunoTech Inc. stock keep raising dividendsJuly 2025 News Drivers & Safe Entry Trade Signal Reports - newser.com
Can AIM ImmunoTech Inc. (HXB) stock sustain breakout momentumWeekly Risk Report & Free Verified High Yield Trade Plans - newser.com
How AIM ImmunoTech Inc. (HXB) stock compares with top peersTrade Entry Summary & Long-Term Safe Investment Ideas - newser.com
Can AIM ImmunoTech Inc. (HXB) stock hit consensus price targetsProfit Target & Advanced Swing Trade Entry Alerts - newser.com
How AIM ImmunoTech Inc. stock stacks up against competitorsTrade Performance Summary & Verified Swing Trading Watchlists - newser.com
How AIM ImmunoTech Inc. (HXB) stock performs in volatility spikesMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
AIM ImmunoTech Secures Patent in Japan Through 2039 for - GlobeNewswire
AIM ImmunoTech Secures Japan Patent for Ampligen in Cancer Treat - GuruFocus
AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors - The Manila Times
Novel Cancer Therapy Patent Victory: AIM ImmunoTech's Ampligen Combo Shows Promise in Phase 2 Trials - Stock Titan
Analyzing AIM ImmunoTech (NYSE:AIM) and ZIVO Bioscience (NASDAQ:ZIVO) - Defense World
AIM ImmunoTech Announces Publication of Journal Article On - GlobeNewswire
AIM ImmunoTech's Ampligen Shows Promise in Cancer Treatment - GuruFocus
Breakthrough Cancer Treatment: AIM ImmunoTech's Ampligen + Interferon Shows Promise Against 'Cold' Tumors - Stock Titan
Maxim Group Sees 133% Upside in AIM ImmunoTech Inc. (AIM) - Insider Monkey
Finanzdaten der AIM ImmunoTech Inc-Aktie (AIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):